Clinical Trial Update: Gene Electrotransfer to Muscle With Plasmid AMEP in Patients With Disseminated Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial investigating gene electrotransfer to muscle using the AMEP plasmid in patients with disseminated cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AMEP plasmid (AMEP)

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Metastatic Malignant Neoplasm | Phase 1 | Status: TERMINATED